Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
Year: 2010
Type: article
Source: NeuroImage
Institutions: Banner - University Medical Center Phoenix, Banner Alzheimer’s Institute, Arizona Alzheimer’s Consortium, Arizona State University, University of California San Diego, University of Arizona, University of California, Los Angeles, University of Utah, University of California, Davis, Nathan Kline Institute for Psychiatric Research, NYU Langone Health, New York University, University of Michigan, University of California, Berkeley, University of California, San Francisco, Translational Genomics Research Institute
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Alzheimer's Association, Eli Lilly and Company, Pfizer, Alzheimer's Disease Neuroimaging Initiative, Novartis Pharmaceuticals Corporation, National Institutes of Health, U.S. Food and Drug Administration, Forest Laboratories, National Institute on Aging, National Institute of Mental Health, National Institute of Biomedical Imaging and Bioengineering
Awards: G104586243, G1057832294, G1315589061, UC Davis Alzheimer's Disease Core Center, Neuroanatomical Substrates of Aging & Cognitive Decline, G148514752, G1510976155, G1557667123, G2835601961, G4076092645, G535261599, Alzheimer's Disease Neuroimaging Initiative, Arizona Alzheimer's Disease Core Center, Clinical Correlates of Longitudinal PET Changes in AD
OpenAlex ID: W2158728639